205 related articles for article (PubMed ID: 35250881)
1. Identifying and Validating of an Autophagy-Related Gene Signature for the Prediction of Early Relapse in Breast Cancer.
Min Y; Feng Y; Luo H; Hu D; Wei X; He D; Yin G; Fan S
Front Endocrinol (Lausanne); 2022; 13():824362. PubMed ID: 35250881
[TBL] [Abstract][Full Text] [Related]
2. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.
Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G
Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of a robust autophagy-related molecular model for predicting the prognosis of breast cancer patients.
Ma JY; Liu Q; Liu G; Peng S; Wu G
Aging (Albany NY); 2021 Jun; 13(12):16684-16695. PubMed ID: 34185683
[TBL] [Abstract][Full Text] [Related]
5. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of autophagy-related prognostic genes in breast cancer.
Lai J; Chen B; Mok H; Zhang G; Ren C; Liao N
J Cell Mol Med; 2020 Aug; 24(16):9145-9153. PubMed ID: 32618109
[TBL] [Abstract][Full Text] [Related]
9. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
Wang Y; Zhang L; Wang B; Cheng Y
Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
[TBL] [Abstract][Full Text] [Related]
10. Nomogram based on autophagy related genes for predicting the survival in melanoma.
Deng G; Wang W; Li Y; Sun H; Chen X; Zeng F
BMC Cancer; 2021 Nov; 21(1):1258. PubMed ID: 34809598
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.
Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ
J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405
[TBL] [Abstract][Full Text] [Related]
12. Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients.
Bian Z; Huang X; Chen Y; Meng J; Feng X; Zhang M; Zhang L; Zhou J; Liang C
Int J Med Sci; 2021; 18(1):284-294. PubMed ID: 33390797
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
Zhang R; Zhu Q; Yin D; Yang Z; Guo J; Zhang J; Zhou Y; Yu JJ
Front Oncol; 2020; 10():597569. PubMed ID: 33614483
[TBL] [Abstract][Full Text] [Related]
16. Construction of a prognostic risk assessment model for HER2 + breast cancer based on autophagy-related genes.
Wang F; Fang L; Fu B; Fan C
Breast Cancer; 2023 May; 30(3):478-488. PubMed ID: 36856932
[TBL] [Abstract][Full Text] [Related]
17. A novel circadian cycle-related gene signature for prognosis prediction of patients with breast cancer.
Hu Y; Fan S; Zhu Y; Xie X
Medicine (Baltimore); 2023 May; 102(18):e33718. PubMed ID: 37144994
[TBL] [Abstract][Full Text] [Related]
18. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes.
Yan C; Liu Q; Jia R
Front Oncol; 2022; 12():829045. PubMed ID: 35186763
[TBL] [Abstract][Full Text] [Related]
19. A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme.
Wang Y; Zhao W; Xiao Z; Guan G; Liu X; Zhuang M
J Cell Mol Med; 2020 Apr; 24(7):3807-3821. PubMed ID: 32065482
[TBL] [Abstract][Full Text] [Related]
20. A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.
Li X; Chen J; Yu Q; Huang H; Liu Z; Wang C; He Y; Zhang X; Li W; Li C; Zhao J; Long W
Front Genet; 2021; 12():569318. PubMed ID: 33796128
[No Abstract] [Full Text] [Related]
[Next] [New Search]
